Kestra Private Wealth Services LLC Increases Stock Position in Colgate-Palmolive Company $CL

Kestra Private Wealth Services LLC raised its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 20.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,178 shares of the company’s stock after purchasing an additional 7,937 shares during the period. Kestra Private Wealth Services LLC’s holdings in Colgate-Palmolive were worth $4,021,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Ritholtz Wealth Management raised its holdings in shares of Colgate-Palmolive by 4.1% during the 1st quarter. Ritholtz Wealth Management now owns 57,896 shares of the company’s stock worth $4,934,000 after acquiring an additional 2,287 shares in the last quarter. Breakwater Capital Group bought a new stake in Colgate-Palmolive in the first quarter worth $389,000. Friedenthal Financial purchased a new stake in Colgate-Palmolive during the first quarter valued at $1,080,000. Fifth Third Wealth Advisors LLC raised its stake in Colgate-Palmolive by 10.6% during the first quarter. Fifth Third Wealth Advisors LLC now owns 11,858 shares of the company’s stock valued at $1,011,000 after purchasing an additional 1,133 shares in the last quarter. Finally, OP Asset Management Ltd bought a new position in Colgate-Palmolive during the first quarter valued at $104,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $92.06 on Friday. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a market capitalization of $73.66 billion, a price-to-earnings ratio of 35.82, a PEG ratio of 4.85 and a beta of 0.33. The firm’s 50-day moving average is $88.07 and its 200 day moving average is $87.04.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company earned $0.91 EPS. Research analysts predict that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s payout ratio is currently 82.49%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Royal Bank Of Canada restated an “outperform” rating and issued a $102.00 target price on shares of Colgate-Palmolive in a report on Monday, May 4th. Sanford C. Bernstein began coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price target for the company. Barclays boosted their price objective on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, UBS Group lifted their target price on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.